AtonRa Partners’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | $213K | Sell |
2,789
-312
| -10% | -$23.8K | 0.42% | 106 |
|
|
2023
Q3 | $215K | Buy |
3,101
+9
| +0.3% | +$624 | 0.45% | 107 |
|
|
2023
Q2 | $292K | Sell |
3,092
-600
| -16% | -$56.6K | 0.45% | 100 |
|
|
2023
Q1 | $305K | Sell |
3,692
-519
| -12% | -$42.9K | 0.45% | 101 |
|
|
2022
Q4 | $314K | Sell |
4,211
-952
| -18% | -$71K | 0.4% | 100 |
|
|
2022
Q3 | $427K | Sell |
5,163
-854
| -14% | -$70.6K | 0.42% | 98 |
|
|
2022
Q2 | $572K | Sell |
6,017
-9,108
| -60% | -$866K | 0.53% | 93 |
|
|
2022
Q1 | $1.78M | Sell |
15,125
-7,621
| -34% | -$897K | 0.97% | 39 |
|
|
2021
Q4 | $2.95M | Buy |
22,746
+7,885
| +53% | +$1.02M | 1.02% | 43 |
|
|
2021
Q3 | $1.68M | Buy |
14,861
+2,244
| +18% | +$254K | 0.56% | 73 |
|
|
2021
Q2 | $1.31M | Sell |
12,617
-830
| -6% | -$86K | 0.48% | 75 |
|
|
2021
Q1 | $1.13M | Sell |
13,447
-11,778
| -47% | -$985K | 0.5% | 80 |
|
|
2020
Q4 | $2.3M | Buy |
+25,225
| New | +$2.3M | 1.13% | 40 |
|